Do you have a monoclonal antibody or polyclonal antibody your laboratory has manufactured? Have you published the reagent in scientific literature?
Would you be interested in commercialising your monoclonal antibody or polyclonal antibody?
After publication, it is usual to allow peers access to your monoclonal antibody or polyclonal antibody. However, this can involve an administrative burden and a deflection of resources in manufacturing / dispensing samples rather than continuing research. An alternative is to work with ImmunoKontact by licensing your reagent. Using your cell line / hybridoma, we can manufacture your monoclonal antibody or polyclonal antibody, purify / conjugate and dispense it.
Your reagent will be internationally available through ImmunoKontact and associated distributors. Licensing will also generate revenue for your group / institute or provide you with access to important reagents free of charge. Licensing is a relatively simple process. Many monoclonal antibodies and polyclonal antibodies listed on this web site are collaborations with researchers. We have licensing agreements with researchers in the USA, UK, Germany and Switzerland. We are willing to consider a variety of proposals and research areas including apoptosis, angiogenesis, cell proliferation, cell signalling, cytokines, phosphorylation and TLR. To discuss potential licensing opportunities please Contact us.